IP Library Granted Patent US 11,413,255
Granted Patent B2
US 11,413,255 · App. 15/735,214 · Granted Aug 16, 2022

Multifunctional cytoprotectant for treatment of pathogenic processes mediated by oxidative stress and toxic electrophiles

Inventors: Richard M. LoPachin (New Rochelle, NY); Terrence Gavin; Brian Geohagen (New York, NY)
Assignee: Montefiore Medical Center
A61K31/12A01N1/0226A61K31/05A61K31/095A61K31/167A61K31/36A61K31/381A61K31/402A61K31/495A61K31/5375A61P39/06C07C49/80C07C49/807C07C49/825C07C49/84C07C233/33C07C323/22C07D207/04C07D207/325C07D295/112C07D333/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,413,255
App. No.
15/735,214
Granted
Aug 16, 2022
Kind
B2
Abstract

Methods, filters and compositions are disclosed for treating toxicity due to oxidative stress and toxic electrophiles.

Claims (15)

1. A compound having the structure:

wherein R 1 is alkyl, cycloalkyl, or

R 2 is NH 2 , NHCOR 3 , NH-alkyl, SH, S-alkyl, or S-aryl, or

wherein R 3 is hydrogen or alkyl;

or a tautomer, a geometric isomer, an optical isomer, a racemate, or a pharmaceutically acceptable salt thereof.

2. A pharmacological composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.

3. A formulation of a compound of claim 1 , wherein the compound is present in an amount effective to increase the viability of an organ for transplantation.

4. A composition comprising a compound of claim 1 for treating toxicity associated with a therapeutic agent, wherein the composition comprises a therapeutically effective amount of the compound.

5. A filter comprising a compound of claim 1 for reducing toxicity associated with an environmental agent or toxin, wherein the filter comprises a therapeutically effective amount of the compound.

6. The compound of claim 1 , wherein any alkyl is independently C1-C6 alkyl.

7. The compound of claim 1 , wherein any alkyl is independently C1-C3 alkyl.

8. A compound having the structure:

or a tautomer; a geometric isomer, an optical isomer; a racemate, or a pharmaceutically acceptable salt thereof.

9. The compound of claim 1 , wherein the cycloalkyl is independently substituted with one or more of ═O, OH, halogen, CH 3 or NH 2 .

10. The compound of claim 1 , wherein any alkyl is a branched alkyl or an unbranched alkyl.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2020
From: LOPACHIN, RICHARD M.; GAVIN, TERRENCE
To: MONTEFIORE MEDICAL CENTER
Reel/Frame 052015/0658 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2019
From: GEOHAGEN, BRIAN
To: MONTEFIORE MEDICAL CENTER
Reel/Frame 049300/0835 →
Continuity (2)
Provisional Application 62185801 · Jun 29, 2015
Related Publication 20180169037A1 · Jun 21, 2018
Cited By (1)
US 12,697,310